Accelerating the path to regulatory submission with RWD
The use of real-world data (RWD) in pharmaceutical development is becoming increasingly prevalent...
The therapeutic market that you know is shaped by the healthcare data that you can see. But when critical medical, specialty, clinical or longitudinal signals are absent from that view, the picture (and the decisions based on it) is less clear. ...
The use of real-world data (RWD) in pharmaceutical development is becoming increasingly prevalent...
With the start of 2024, we are moving toward a world without third-party cookies to track consumer...
With recent disruptions in the availability of real-world data (RWD) for clinical research,...
While the CDC is considered the nation’s leading authority on infectious diseases, it is also...
With advances in artificial intelligence (AI) making headlines almost daily, the life sciences...
An interview with Kristijan Kahler, executive director of innovation evidence at Novartis While...
Given its role at the intersection of novel real-world data and emerging technologies, HealthVerity...
Our series on how Privacy Preserving Record Linkage (PPRL) technology can help government agencies...
HealthVerity is proud to partner with Inovalon, the largest closed claims data source in the U.S.,...
In our ongoing series on how Privacy-Preserving Record Linkage (PPRL) technology can help...
Know what closed payer claims can reveal about patient journeys, treatment persistence and the commercial opportunities behind the data A patient starts therapy. But what happens next? Do they persist, switch or discontinue? For commercial teams, und...